1Globe Capital LLC and Jiaqiang Li's Ownership in Crescent Biopharma, Inc.

1Globe Capital LLC and Jiaqiang Li have filed a Schedule 13G with the SEC, disclosing their ownership in Crescent Biopharma, Inc. Each reporting person owns 6.45% of the company's ordinary shares, based on 13,892,562 shares outstanding as of July 25, 2025. The shares are held with shared voting and dispositive power, totaling 896,712 shares for each reporting person. Jiaqiang Li, who serves as the Chairman of 1Globe Capital LLC, may be deemed the ultimate beneficial owner of these shares. Both reporting persons disclaim beneficial ownership of securities not directly owned by them, except to the extent of their pecuniary interest. The filing was made under Rule 13d-1(c) and was signed on August 20, 2025.